Management of phosphate in chronic kidney disease--Clinical trials of lanthanum carbonate

Authors
Category Primary study
JournalClinical calcium
Year 2009
The lanthanum carbonate which is the new phosphate binder decreased serum phosphorus value significantly in comparison with the placebo group, showed equal serum phosphorus decrease action to those at the capacity which in addition is less than calcium carbonate and sevelamer hydrochloride.
Epistemonikos ID: 391219a22986f3146438a529faad222bc92545b0
First added on: Oct 02, 2023